Imaging3 CEO Misled Investors About 3-D Device, SEC Says

Law360, New York (June 26, 2013, 7:08 PM EDT) -- The U.S. Securities Exchange Commission sued medical device maker Imaging3 Inc. and its founder in California federal court Tuesday for allegedly downplaying the U.S. Food and Drug Administration's negative evaluation of a 3-D imaging product during a shareholders' conference call.

The complaint claims CEO Dean Janes with fraud. Janes runs the California-based maker of the Dominion Scanner, a device designed to scan and produce 3-D images of most parts of the human body. The complaint accuses him of omitting key information about why the FDA would...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Securities and Exchange Commission v. Imaging3 Inc et al


Case Number

2:13-cv-04616

Court

California Central

Nature of Suit

Securities/Commodities

Judge

Gary A. Feess

Date Filed

June 25, 2013

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.